Warning: The NCBI web site requires JavaScript to function. more...
N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome.
Fulghesu AM, Ciampelli M, Muzj G, Belosi C, Selvaggi L, Ayala GF, Lanzone A.
Fertil Steril. 2002 Jun;77(6):1128-35.
Related citations
Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism.
Villa P, Valle D, Mancini A, De Marinis L, Pavone V, Fulghesu AM, Mancuso S, Lanzone A.
Fertil Steril. 1999 Jan;71(1):115-21.
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
Fertil Steril. 2008 Apr;89(4):899-906. Epub 2007 Nov 5.
ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance.
Uncu G, Ozyurek SE, Uncu Y.
Fertil Steril. 2007 Sep;88(3):670-4. Epub 2007 Apr 23.
Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.
Int J Obes (Lond). 2008 Apr;32(4):692-9. Epub 2007 Dec 11.
Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism.
Paoletti AM, Cagnacci A, Orrù M, Ajossa S, Guerriero S, Melis GB.
Fertil Steril. 1999 Sep;72(3):448-53.
Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity.
Baillargeon JP, Carpentier A.
Fertil Steril. 2007 Oct;88(4):886-93. Epub 2007 Jun 7.
Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF, Nilas L, Madsbad S, Holst JJ.
Metabolism. 2009 May;58(5):586-93.
The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
Yilmaz M, Biri A, Karakoç A, Törüner F, Bingöl B, Cakir N, Tiras B, Ayvaz G, Arslan M.
J Endocrinol Invest. 2005 Dec;28(11):1003-8.
Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome.
Fulghesu AM, Angioni S, Portoghese E, Milano F, Batetta B, Paoletti AM, Melis GB.
Fertil Steril. 2006 Aug;86(2):398-404. Epub 2006 Jun 12.
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.
Lanzone A, Fulghesu AM, Guido M, Fortini A, Caruso A, Mancuso S.
Fertil Steril. 1992 Aug;58(2):296-301.
Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome.
Romualdi D, Giuliani M, Draisci G, Costantini B, Cristello F, Lanzone A, Guido M.
Fertil Steril. 2007 Jul;88(1):131-8. Epub 2007 Mar 6.
A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.
Legro RS, Finegood D, Dunaif A.
J Clin Endocrinol Metab. 1998 Aug;83(8):2694-8.
N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study.
Elnashar A, Fahmy M, Mansour A, Ibrahim K.
Fertil Steril. 2007 Aug;88(2):406-9. Epub 2007 Mar 1.
Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.
Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Rosenfield RL, Polonsky KS.
J Clin Endocrinol Metab. 1997 Jul;82(7):2108-16.
Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome.
Glintborg D, Hermann AP, Andersen M, Hagen C, Beck-Nielsen H, Veldhuis JD, Henriksen JE.
Fertil Steril. 2006 Aug;86(2):385-97. Epub 2006 Jun 16.
Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V, Nagamani M.
J Soc Gynecol Investig. 2005 Feb;12(2):129-34.
Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
Arslanian SA, Lewy V, Danadian K, Saad R.
J Clin Endocrinol Metab. 2002 Apr;87(4):1555-9.
Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study.
Cucinelli F, Soranna L, Perri C, Barini A, Cento RM, Mancuso S, Lanzone A.
Fertil Steril. 2004 Apr;81(4):1047-54.
Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action.
Aroda V, Ciaraldi TP, Chang SA, Dahan MH, Chang RJ, Henry RR.
Fertil Steril. 2008 May;89(5):1200-8. Epub 2007 Aug 13.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on